| Serial Number | 87329452 |
| Word Mark | BIOHAVEN |
| Filing Date | Wednesday, February 8, 2017 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 18, 2020 |
| Registration Number | 6130617 |
| Registration Date | Tuesday, August 18, 2020 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 6, 2018 |
| Goods and Services | Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses; pharmaceutical preparations for the treatment of brain ischemia; pharmaceutical preparations for the treatment of brain ischemia, namely, post-stroke recovery, severe intracranial atherosclerosis, carotid endarterectomy, cardiac bypass, cerebral vasculitis, reversible cerebral vasoconstriction syndrome; pharmaceutical preparations for the treatment of brain and cord injuries; pharmaceutical preparations for the treatment of brain and cord injuries, namely, post- intracranial hemorrhage recovery, traumatic brain injury, spinal cord injury; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), Amyotrophic Lateral Sclerosis (ALS), Huntington's disease, Lewy body dementia, frontotemporal dementia, vascular dementia, Parkinson's disease, cognitive impairment of aging, progressive Multiple Sclerosis; pharmaceutical preparations for the treatment of optic and retinal neuropathies; pharmaceutical preparations for the treatment of optic and retinal neuropathies, namely, glaucoma, diabetic retinopathy, ischemic optic and retinal neuropathies; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, opioid sparing analgesia, cancer pain, chronic neuropathic pain, peripheral neuropathy, low back pain in the nature of failed back surgery syndrome, radiculopathy in the nature of sciatica, diabetic peripheral neuropathy, post-herpetic neuralgia, chemotherapy induced neuropathy and other medication induced neuropathies, complex regional pain syndrome, fibromyalgia, chronic post-operative pain, cluster thoracotomy, phantom limb, stump neuroma; pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia; pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, breath holding in Rett syndrome, dystonias, dysphagia, gait abnormalities, bulbar function in ALS, pseudobulbar affect, levodopa-induced dyskinesias in Parkinson's disease, agitation in AD, disinhibition in dementia; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of epilepsy, namely, precision medicine - adjuvant for genetic epilepsy due to NMDA receptor mutations with hyperactivation; pharmaceutical preparations for the treatment of neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, treatment resistant depression, Post Traumatic Stress Disorder (PTSD) in the nature of hyperarousal, substance abuse disorders, addiction disorders, Obsessive Compulsive Disorder (OCD), hoarding, trichotillomania, eating disorders, Generalized Anxiety Disorder (GAD), adjustment disorders, panic disorder, major depressive episode, bipolar disorder in the nature of manic and depressive episodes, dysthymia, cyclothymia, psychotic disorders, schizophrenia; pharmaceutical preparations for the treatment of cerebellar disorders; pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia, Friedriech's ataxia, multisystem atrophy, essential tremor; pharmaceutical preparations for the treatment of hearing disorders, tinnitus, delirium, sleep disorders, parasomnias, learning disorders, Attention Deficit Disorder (ADD), Pervasive Developmental Disorders (PDD), Asperger's syndrome, autism, menopausal hot flashes; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, namely, monotherapy and adjunctive use |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 14, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, March 13, 2020 |
| First Use In Commerce Date | Friday, March 13, 2020 |
| Party Name | BIOHAVEN THERAPEUTICS LTD. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 99 - Other |
| Address | Road Town, Tortola VG1110 VG |
| Party Name | Biohaven Pharmaceutical Holding CompanyLimited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | New Haven, CT 06510 |
| Party Name | Biohaven Pharmaceutical Holding CompanyLimited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | New Haven, CT 06510 |
| Party Name | Biohaven Pharmaceutical Holding CompanyLimited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | New Haven, CT 06510 |
| Event Date | Event Description |
| Monday, April 17, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, April 17, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, April 17, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, April 17, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, April 17, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, January 11, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Monday, June 21, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, June 21, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, June 21, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, June 21, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, June 21, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, August 26, 2020 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Tuesday, August 18, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, July 16, 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Wednesday, July 15, 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Thursday, June 25, 2020 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, June 23, 2020 | USE AMENDMENT FILED |
| Tuesday, June 23, 2020 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, May 14, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 13, 2020 | SOU EXTENSION 4 GRANTED |
| Friday, May 1, 2020 | SOU EXTENSION 4 FILED |
| Wednesday, May 13, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, May 1, 2020 | SOU TEAS EXTENSION RECEIVED |
| Monday, February 3, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, February 3, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, January 13, 2020 | WITHDRAWAL OF ATTORNEY GRANTED |
| Monday, January 13, 2020 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Friday, October 25, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, October 23, 2019 | SOU EXTENSION 3 GRANTED |
| Wednesday, October 23, 2019 | SOU EXTENSION 3 FILED |
| Wednesday, October 23, 2019 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, October 23, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, October 23, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, April 26, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, April 24, 2019 | SOU EXTENSION 2 GRANTED |
| Wednesday, April 24, 2019 | SOU EXTENSION 2 FILED |
| Wednesday, April 24, 2019 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, September 12, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, September 10, 2018 | SOU EXTENSION 1 GRANTED |
| Monday, September 10, 2018 | SOU EXTENSION 1 FILED |
| Monday, September 10, 2018 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, May 1, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 6, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 6, 2018 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 14, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, February 1, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, January 30, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 30, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 26, 2018 | ASSIGNED TO LIE |
| Tuesday, January 16, 2018 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, January 8, 2018 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, January 8, 2018 | FINAL REFUSAL E-MAILED |
| Monday, January 8, 2018 | FINAL REFUSAL WRITTEN |
| Friday, December 15, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 14, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 14, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 21, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, June 21, 2017 | NON-FINAL ACTION E-MAILED |
| Wednesday, June 21, 2017 | NON-FINAL ACTION WRITTEN |
| Tuesday, May 9, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, May 9, 2017 | NON-FINAL ACTION E-MAILED |
| Tuesday, May 9, 2017 | NON-FINAL ACTION WRITTEN |
| Wednesday, May 3, 2017 | ASSIGNED TO EXAMINER |
| Tuesday, February 14, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, February 13, 2017 | NEW APPLICATION ENTERED |